Fenglan Feng - Concepedia

Author

Fenglan Feng

Guangzhou Medical University

Also Known As

FENGLAN FENG, Feng-Lan Feng, Fenglan Feng

Publications

283

Citations

H-Index

Concepts

All Affiliations

Guangzhou Medical University First Affiliated Hospital of Guangzhou Medical University State Key Laboratory of Respiratory Disease National Clinical Research Center for Digestive Diseases Peking University

About

Fenglan Feng is an author at Guangzhou Medical University specializing in tumor biology, medicine, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	139
2	Cell Biology	4	4	139
3	Engineering	1	1	33
4	Cellular Physiology	1	1	51
5	Chemical Engineering	1	1	33

Fenglan Feng

Publications

268

Citations

H-Index

Page 1

	Year	Citations
RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers Xueda Hu, Jingyi Chen, Xiaoshun Shi, Tumor Biology Tumor BiologyNon-small-cell Lung CancersTumor MigrationOncogenic AgentMedicine	2017	56
Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments Wei Ye, Zhiwu Jiang, Guan-Xiong Li, Journal of Hematology & Oncology	2015	51
The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer Jin Li, Jie Ting Zhang, Xiaohua Jiang, International Journal of Oncology Tumor BiologyPrognostic BiomarkersOncologyTumor MicroenvironmentMedicine	2015	51
Study on sodium acetate trihydrate-expand graphite-carbon nanotubes composite phase change materials with enhanced thermal conductivity for waste heat recovery Wanchun Sun, Guohao Liang, Fenglan Feng, Journal of Energy Storage Materials ScienceChemical EngineeringEnhanced Thermal ConductivityEngineeringCarbon-based Material	2022	33
A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes Jin Li, Yaoqi Chen, Xiaoshun Shi, Journal of Thoracic Disease	2017	28
Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer Jin Li, Lin Ye, Xiaoshun Shi, Oncotarget Nsclc MetastasisTumor MicroenvironmentRepulsive Guidance MoleculesNsclc Cell LinesMedicine	2016	19
Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer Jingyi Chen, Yusong Chen, Fenglan Feng, Journal of Thoracic Disease	2018	17
RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting Yichu Nie, Fenglan Feng, Wei Luo, Cancer Gene Therapy Lung AdenocarcinomaCancer BiologyTumor BiologyTumor ImmunityCancer Cell Biology	2022	13

Page 1